Company: CVS Health Corporation
Ticker: CVS
Form: 10-K
Filed: 2026-02-10
Fiscal Period: {"fp": "FY", "fy": 2025}

Question: What was CVS Health Corporation's total assets in fiscal year 2025?
Question Type: value_lookup

Concept: Assets
Answer (Numeric): 253538.0
Answer (Display): $253,538 million
Unit: USD millions

Evidence:
[{"chunk_id": "268", "equivalent_chunk_ids": ["268"], "section": "Consolidated Balance Sheets", "supports": ["main"], "text": "At December 31,\nIn millions, except per share amounts\nAssets:\nCash and cash equivalents\n8,453\n8,586\nInvestments\n2,145\n2,407\nAccounts receivable, net\n39,779\n36,469\nInventories\n19,246\n18,107\nOther current assets\n5,091\n3,076\nTotal current assets\n74,714\n68,645\nLong-term investments\n32,669\n28,934\nProperty and equipment, net\n13,083\n12,993\nOperating lease right-of-use assets\n14,973\n15,944\nGoodwill\n85,478\n91,272\nIntangible assets, net\n25,508\n27,323\nSeparate accounts assets\n1,994\n3,311\nOther assets\n5,119\n4,793\nTotal assets\n253,538\n253,215\nLiabilities:\nAccounts payable\n17,641\n15,892\nPharmacy claims and discounts payable\n26,344\n24,166\nHealth care costs payable\n15,399\n15,064\nAccrued expenses and other current liabilities\n22,387\n20,810\nOther insurance liabilities\n1,116\n1,183\nCurrent portion of operating lease liabilities\n1,737\n1,751\nShort-term debt\n2,119\nCurrent portion of long-term debt\n4,068\n3,624\nTotal current liabilities\n88,692\n84,609\nLong-term operating lease liabilities\n13,643\n14,899\nLong-term debt\n60,502\n60,527\nDeferred income taxes\n3,832\n3,806\nSeparate accounts liabilities\n1,994\n3,311\nOther long-term insurance liabilities\n4,716\n4,902\nOther long-term liabilities\n4,777\n5,431\nTotal liabilities\n178,156\n177,485\nCommitments and contingencies (Note 18)\nShareholders’ equity:\nPreferred stock, par value $\n0.01\nshares authorized;\nnone\nissued or outstanding\nCommon stock, par value $\n0.01\n3,200\nshares authorized;\n1,787\nshares issued and\n1,271\nshares outstanding at December 31, 2025 and\n1,778\nshares issued and\n1,260\nshares outstanding at December 31, 2024 and capital surplus\n50,402\n49,661\nTreasury stock, at cost:\nand\nshares at December 31, 2025 and 2024\n36,790\n36,818\nRetained earnings\n61,196\n62,837\nAccumulated other comprehensive income (loss)\nTotal CVS Health shareholders’ equity\n75,214\n75,560\nNoncontrolling interests\nTotal shareholders’ equity\n75,382\n75,730\nTotal liabilities and shareholders’ equity\n253,538\n253,215\nSee accompanying notes to consolidated financial statements."}]

Derivation: